T2DM

9 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Phase 2(2)

Drug	Company
GSBR-1290	Structure Therapeutics Inc. (GPCR) Analyze with AI →
vanoglipel	MetaVia Inc. (MTVA) Analyze with AI →

Phase 1(3)

Drug	Company
agtx-2004	Agentix Corp. (AGTX) Analyze with AI →
AGTX-2004 (DBPR211)	Agentix Corp. (AGTX) Analyze with AI →
Dulaglutide	ELI LILLY & Co (LLY) Analyze with AI →

Phase 1/Phase 2(3)

Drug	Company
ALN-4324	ALNYLAM PHARMACEUTICALS, INC. (ALNY) Analyze with AI →
ALN-KHK	ALNYLAM PHARMACEUTICALS, INC. (ALNY) Analyze with AI →
asc30	CHINA PHARMA HOLDINGS, INC. (CPHI) Analyze with AI →

Phase 4(1)

Drug	Company
Semaglutide	UNITED THERAPEUTICS Corp (UTHR) Analyze with AI →

BioSniper tracks 9 drugs in development for T2DM across 7 companies.

There are 1 clinical trial targeting T2DM tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.